Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shalin Kothari

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Blood Cancer Discovery|December 19, 2022
Genetic Modeling of B-cell State Transitions for Rational Design of Lymphoma TherapiesEtienne Leveille, Shalin Kothari, Markus Müschen
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 7, 2017
Striking a Happy MediumShalin Kothari, Francisco Hernandez-Ilizaliturri, Pallawi Torka
Springerplus|March 12, 2013
Multiple isolated extramedullary relapse of acute promyelocytic leukemia after allogeneic hematopoietic stem cell transplant: a case report and review of literatureShalin Kothari, Geoffrey Herzig, Stephen Slone, et al.
Journal of Medical Case Reports|June 16, 2016
Crizotinib in anaplastic lymphoma kinase-positive anaplastic large cell lymphoma in the setting of renal insufficiency: a case reportShalin Kothari, Najam Ud-Din, Michele Lisi, et al.
Current Hematologic Malignancy Reports|January 24, 2019
Determination of Minimal Residual Disease in Multiple Myeloma: Does It Matter?Shalin Kothari, Jens Hillengass, Philip L McCarthy, et al.
Leukemia & Lymphoma|August 25, 2020
Cost-effectiveness of polatuzumab vedotin in relapsed or refractory diffuse large B-cell lymphomaKishan K Patel, Iris Isufi, Shalin Kothari, et al.
Cancer Discovery|September 4, 2024
Tuning Responses to Polatuzumab Vedotin in B-cell LymphomaEtienne Leveille, Shalin Kothari, Kadriye N Cosgun, et al.
The Oncologist|January 18, 2023
Optimization of Radium-223 Treatment of Castration-resistant Prostate Cancer Based on the Burden of Skeletal Metastasis and Clinical ParametersAhmad Shariftabrizi, Shalin Kothari, Saby George, et al.
Blood|June 11, 2020
Cost-effectiveness of first-line vs third-line ibrutinib in patients with untreated chronic lymphocytic leukemiaKishan K Patel, Iris Isufi, Shalin Kothari, et al.
Frontiers in Oncology|September 30, 2021
Comprehensive Clinicopathologic and Molecular Analysis of Mast Cell Leukemia With Associated Hematologic Neoplasm: A Report and In-Depth Study of 5 CasesPhilippa Li, Giulia Biancon, Timil Patel, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Blood Cancer Discovery|December 19, 2022
Genetic Modeling of B-cell State Transitions for Rational Design of Lymphoma TherapiesEtienne Leveille, Shalin Kothari, Markus Müschen
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 7, 2017
Striking a Happy MediumShalin Kothari, Francisco Hernandez-Ilizaliturri, Pallawi Torka
Springerplus|March 12, 2013
Multiple isolated extramedullary relapse of acute promyelocytic leukemia after allogeneic hematopoietic stem cell transplant: a case report and review of literatureShalin Kothari, Geoffrey Herzig, Stephen Slone, et al.
Journal of Medical Case Reports|June 16, 2016
Crizotinib in anaplastic lymphoma kinase-positive anaplastic large cell lymphoma in the setting of renal insufficiency: a case reportShalin Kothari, Najam Ud-Din, Michele Lisi, et al.
Current Hematologic Malignancy Reports|January 24, 2019
Determination of Minimal Residual Disease in Multiple Myeloma: Does It Matter?Shalin Kothari, Jens Hillengass, Philip L McCarthy, et al.
Leukemia & Lymphoma|August 25, 2020
Cost-effectiveness of polatuzumab vedotin in relapsed or refractory diffuse large B-cell lymphomaKishan K Patel, Iris Isufi, Shalin Kothari, et al.
Cancer Discovery|September 4, 2024
Tuning Responses to Polatuzumab Vedotin in B-cell LymphomaEtienne Leveille, Shalin Kothari, Kadriye N Cosgun, et al.
The Oncologist|January 18, 2023
Optimization of Radium-223 Treatment of Castration-resistant Prostate Cancer Based on the Burden of Skeletal Metastasis and Clinical ParametersAhmad Shariftabrizi, Shalin Kothari, Saby George, et al.
Blood|June 11, 2020
Cost-effectiveness of first-line vs third-line ibrutinib in patients with untreated chronic lymphocytic leukemiaKishan K Patel, Iris Isufi, Shalin Kothari, et al.
Frontiers in Oncology|September 30, 2021
Comprehensive Clinicopathologic and Molecular Analysis of Mast Cell Leukemia With Associated Hematologic Neoplasm: A Report and In-Depth Study of 5 CasesPhilippa Li, Giulia Biancon, Timil Patel, et al.
Pageof 3